A Study Evaluating the Safety, Pharmacokinetics, and Preliminary Activity of GDC-1261 in Participants With Advanced or Metastatic Prostate Cancer
Clinical trial NCT07567846 · RECRUITING
Trial details
- NCT number
- NCT07567846
- Sponsor
- Genentech, Inc.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-29
- Primary completion
- 2027-11-30
- Enrollment
- 260
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.